Risk factors and genotypes of hepatitis C virus infection in libyan patients

Wa Alashek1, M Altagdi

  • 1Community Medicine Department, Faculty of Medicine, Alfateh Medical University, Tripoli, Libya.

Insights

Hepatitis C virus (HCV) genotypes 1 and 4 are most common in Libyan patients. Males are more frequently affected and present at a younger age, highlighting the need for improved infection control.

Area of Science:

  • Hepatology
  • Virology
  • Epidemiology

Background:

  • Hepatitis C virus (HCV) infection prevalence and incidence vary globally due to diverse risk factors.
  • Identifying HCV genotypes is crucial for understanding disease epidemiology.
  • This study aimed to describe HCV genotype distribution and its association with risk factors in Libyan patients.

Purpose of the Study:

  • To determine the distribution of HCV genotypes among patients attending the Tripoli Medical Centre.
  • To investigate the relationship between HCV genotypes and patient risk factors.
  • To inform public health strategies for HCV prevention and control in Libya.

Main Methods:

  • Retrospective review of medical records of 891 Libyan chronic HCV patients (2003-2007).
  • Data collected included age, gender, risk factors, and family history.
  • Statistical analysis employed t-tests, chi-squared tests, and contingency coefficient tests.

Main Results:

  • HCV genotypes 1 (30.9%) and 4 (29.2%) were most prevalent. Genotypes 2 and 3 accounted for 19.3% and 13.6%, respectively.
  • HCV infection was more common in males (P<0.001), who also showed a higher prevalence of Genotype 3 (88.6%).
  • Significant associations were found between HCV genotype and risk factors including hospitalization/surgery (33%), blood transfusion (22.7%), intravenous drug abuse (15%), and dental procedures (15.9%).

Conclusions:

  • Hepatitis C virus genotypes 1 and 4 predominate in the studied Libyan population.
  • Males are disproportionately affected by HCV and tend to be diagnosed at a younger age.
  • Findings underscore the necessity of stringent infection control in healthcare settings and community-based interventions for intravenous drug users to curb HCV transmission.
Abstract

Related Concept Videos

Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
Yellow Fever01:18

Yellow Fever

Yellow fever is a viral hemorrhagic disease caused by the yellow fever virus (YFV), a member of the Flaviviridae family. It is transmitted primarily by Aedes and Haemagogus mosquitoes in tropical and subtropical regions of Africa and South America. After transmission through a mosquito bite, the virus initially replicates in skin-resident immune cells such as dendritic cells and macrophages. These cells then migrate to the lymph nodes, where viral replication increases, eventually leading to...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...